We're doing two doses! Just with a larger gap in between. Yes, the data is patchy but so far it's coming back as approx 75% protection from one dose, and identical (or even slightly boosted) protection after the delayed second dose compared to the shorter schedule.

I trust "the math" that shows a better population outcome there, even though individuals will have higher risk profiles this way.